News Releases

Read all the latest news from Bristol Myers Squibb the Netherlands here.

Bristol Myers Squibb celebrates highest point in first European cell therapy production facility construction at Leiden Bio Science Park >
The construction of the CAR T cell therapy production centre of Bristol Myers Squibb in the Leiden Bio Science Park (LBSP) is nearing completion. Today the highest point was reached which traditionally means a topping-off ceremony. 

#MSconnections on World MS Day >
World MS Day is coming up on May 30, 2022: a day for the global MS community to come together and share their stories; offering each other support, but also creating more awareness about the truth of living with multiple sclerosis (MS). In honour of this day, Evelijne from Bristol Myers Squibb was asked to be a guest host of the Instagram page of Platform MS, one of the largest online communities for MS patients in the Netherlands. Every week someone new gets the chance to tell his/her story via the page.
World MS Day

The importance of diversity and equity in clinical trials  >
The “Global Impact in Health” Symposium in Leiden brings together the life science community to think through ways of improving some of our most critical health dilemmas globally, including diversity and health equity. Anne Kerber, Senior VP and Head of Cell Therapy Development at Bristol Myers Squibb, gave a keynote about the importance of equity and diversity in clinical trials to deliver better science and outcomes for patients. 

Contact details for media

Didn't find the information you were looking for or do you have further questions? Please contact us directly. We will be happy to help you out!

 

Ronald Jager

Senior Manager Corporate Affairs

 

Phone number: +31 30 300 22 22

 

E-mail: info.nl@bms.com

 

For all other questions

If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!